Eric M Poeschla

Title: Eric M Poeschla: Innovator in Gene Therapy

Introduction

Eric M Poeschla is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of gene therapy, particularly through his innovative work with lentiviral vectors and HIV-2 proviruses. With a total of 4 patents, his research has the potential to impact the treatment of various medical conditions.

Latest Patents

One of his latest patents is titled "Lentiviral nucleic acids and uses thereof." This invention provides non-primate lentiviral vectors, packaging cells, and packaging plasmids based on feline and ungulate retroviruses. The packaging plasmids are specifically designed for expression in human cells, which are also utilized as packaging cells. The vectors developed by Poeschla are capable of transducing human cells, including challenging non-dividing cells of the hematopoietic and nervous system, both in vitro and in vivo. These vectors are suitable for general gene transfer and gene therapy aimed at treating conditions mediated by these non-dividing cells, including cancer and HIV infection.

Another significant patent is focused on "Polypeptides encoded by novel HIV-2 proviruses." This patent describes novel HIV-2 proviruses, molecular clones, nucleic acids, polypeptides, viruses, and viral components. The compositions outlined in this patent can be utilized as components of diagnostic assays, immunological reagents, vaccines, packaging cells, cell transduction vectors, and gene therapy vectors.

Career Highlights

Eric M Poeschla is affiliated with the University of California, where he continues to advance his research in gene therapy. His work has garnered attention for its innovative approach to addressing complex medical challenges.

Collaborations

Throughout his career, Poeschla has collaborated with notable scientists, including Flossie Wong-Staal and Gunter Kraus. These collaborations have further enriched his research and contributed to the advancement of gene therapy technologies.

Conclusion

Eric M Poeschla's contributions to the field of gene therapy through his patents and research are noteworthy. His innovative work continues to pave the way for new treatments and therapies that could significantly improve patient outcomes.